In 2022, it is expected that the market for blow fill and seal technology will be worth US$ 3.0 billion, and it will increase at a CAGR of 8.6% to reach US$ 7.0 billion by the end of 2032. By the end of 2022, blow-fill seals had a market share of around 3.3% for pharmaceutical packaging globally. BFS technology is used in the pharmaceutical, food and beverage, cosmetics, and personal care, as well as other industries (chemicals, etc.).
According to estimates, the primary reason propelling the growth of the blow-fill-seal technology market is the rising demand for effective packaging solutions in the pharmaceutical and food and beverage sectors. One key factor driving the pharmaceutical industry’s extensive adoption of blow-fill-seal technology is its accuracy and precision in the manufacture of unit dosage packaging.
Pharmaceutical companies are able to increase the flexibility of ampoules, bottles, vials, prefilled syringes, and injectables thanks to blow-fill seal technology. By using blow-fill seal technology, the equipment is given more flexibility, making it easier to carry and less likely to damage.
According to FactMR research, pharmaceutical businesses are gradually moving away from utilizing rigid raw materials like plastic to package drugs using flexible raw materials like propylene. The significant change can be attributable to these materials’ enhanced stability, shelf-life, and sterility.
Download a Sample Copy of This Report:
The level of automation that is made possible by blow fill seal technology is another factor driving its growth. With the use of technology, pharmaceutical companies are now able to make unit dose packaging units constantly with the fewest possible manufacturing flaws and the least amount of human involvement possible. Single or unit dose packaging is more effective at reducing medication-related human error, which enhances treatment effectiveness overall. In addition, blow-fill seal containers are a reliable packaging choice for medications because they are tamper-evident and temperature-resistant. Unit dose packaging is also increasingly being used in a variety of industries and sectors. Cosmetic firms distribute samples of their products in this simple packing format.
Key Companies Profiled
- Amanta Healthcare Ltd.
- Unither Pharmaceuticals
- Catalent, Inc.
- Curida AS
- Unipharma LLC
- Weiler Engineering, Inc.
- GlaxoSmithKline plc.
- Takeda Pharmaceuticals International AG
- Nephron Pharmaceuticals Corporation
- Horizon Pharmaceuticals, Inc.
- Brevetti Angela S.R.L.
- Recipharm AB
Sustainability Offered by Blow Fill Seal Technology to Propel Widespread Adoption
The appeal of blow fill seal technology is boosted by its sustainable operation, which also offers a way to save healthcare expenses and boost treatment efficacy. Governments all across the world are enacting legislation designed to preserve the environment in response to growing environmental concerns. As a result, businesses are seeking for solutions to help them increase the sustainability of their business operations. The blow fill seal technology has a small carbon footprint, uses less power, and helps cut down on manufacturing waste. Because of these advantages, regulatory systems all over the world advocate integrating blow fill seal technology into the current production chain.
Additionally, blow fill technology help eliminate the requirement of warehousing prefabricated containers for packaging, in turn, decreasing the time to market which can potentially allow for the development of in-house packaging solutions contributing to a substantial reduction in the costs of production. Owing to these factors blow fill seal technology is witnessing widespread adoption in the pharmaceutical and F&B industries. Blow fill seal technology is witnessing widespread adoption in the beverages industry on account of its superior leakproofing and sealing.
The BFS technology market spans various applications, with pharmaceuticals being the primary sector. However, it is gaining traction in the food and beverage industry for packaging products like eye drops, nasal sprays, and oral care solutions. End-users contributing to the growing demand include pharmaceutical companies, contract manufacturers, and packaging firms. Regional variations in pharmaceutical manufacturing and healthcare infrastructure influence the adoption of BFS technology.
Leading companies like Rommelag, Unither Pharmaceuticals, Weiler Engineering, and Catalent, Inc., dominate the Blow Fill Seal technology market, offering state-of-the-art solutions and services. Looking ahead, the future of the BFS technology market appears promising. The rapid expansion of the pharmaceutical industry, particularly in sterile liquid medication production, will continue to drive the demand for BFS technology. With pharmaceutical companies increasingly prioritizing product safety and regulatory compliance, the aseptic capabilities of BFS technology become even more critical. Furthermore, BFS technology’s diversification into the food and beverage industry opens up new avenues for market growth. Ongoing research and development efforts are aimed at further enhancing its efficiency, adaptability, and eco-friendliness. In conclusion, Blow Fill Seal technology is poised to play an increasingly pivotal role in pharmaceutical and other industries, ensuring the safe and efficient delivery of critical products to consumers worldwide.
North America to Hold a Significant Revenue Share of the Blow Fill Seal Technology Market
The presence of advanced infrastructure and mature pharmaceutical market in North American countries is estimated to uphold the demand for blow fill seal technology in the region. The region is estimated to hold over 35% of the market share in 2019. Increasing investments in the pharmaceutical industry coupled with intensifying efforts towards improving healthcare in Western Europe is likely to drive the growth of the market in the region and it is expected to account for the second largest share of the blow fill seal technology market. Latin America is estimated to provide lucrative opportunities for blow fill seal technology manufacturers as pharmaceutical companies in the region continue to shift towards the use of blow fill seal technology for packaging over conventional packaging solutions.
Get Customization on this Report for Specific Research Solutions:
Demand for Polyethylene in BFS Manufacturing to Remain Buoyant
The Fact.MR study opines that out of the different materials utilized in blow fill seal technology, demand for polyethylene is estimated to remain robust. Growing demand for polyethylene can be attributed to its inert nature, low gas and water permeability, and its non-interference properties. Among the different categories of polyethylene materials, demand for low-density polyethylene (LDPE) is estimated to outpace the demand for other materials owing to its resistivity to both bases and acids and its non-reactive property.
Blow Fill Seal (BFS) technology is revolutionizing pharmaceutical packaging, streamlining the manufacturing and packaging processes for liquid medications. This innovative method combines container formation, filling, and sealing into a single continuous operation, ensuring the highest levels of sterility and minimizing the risk of contamination. The BFS process begins with the formation of plastic containers through the controlled blowing of sterile plastic granules into a mold, creating hermetically sealed containers with precise dimensions. Immediately following this step, the containers are filled with liquid pharmaceutical products within an aseptic environment. Subsequently, they are sealed, safeguarding product integrity and sterility until they reach end-users.
The advantages of BFS technology are manifold, making it a preferred choice for pharmaceutical packaging. It excels in aseptic packaging, significantly reducing the potential for microbial contamination. Automated and with minimal human intervention, it further enhances product safety. The single-step process reduces exposure to external factors like oxygen and light, crucial for preserving sensitive pharmaceutical formulations. Additionally, BFS technology allows for the creation of unique container shapes and sizes, facilitating product differentiation and branding.
Segmentation of Blow Fill Seal Technology Industry Research
- By Product Type :
- Above 500ml
- Prefilled Syringes & Injectable
- By Material Type :
- Others (EVOH etc.)
- By End-Use :
- Wound Care
- Respiratory Therapy
- Food & Beverages
- Cosmetics & Personal Care
- Others (Chemicals etc.)
- By Region :
- North America
- Latin America
- East Asia
- South Asia & Oceania
US Sales Office :
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583